Unknown. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Unknown. Zustand: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
Sprache: Englisch
Verlag: Harlequin Enterprises ULC, 2008
ISBN 10: 0373793790 ISBN 13: 9780373793792
Anbieter: Better World Books, Mishawaka, IN, USA
Zustand: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Sprache: Englisch
ISBN 10: 1398854255 ISBN 13: 9781398854253
Anbieter: ThriftBooks-Dallas, Dallas, TX, USA
Hardcover. Zustand: Very Good. No Jacket. Missing dust jacket; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Sprache: Englisch
Verlag: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: Basi6 International, Irving, TX, USA
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Verlag: Performance Programme Dated Saturday 18th March . 2000., 2000
Anbieter: Little Stour Books PBFA Member, Canterbury, Vereinigtes Königreich
Verbandsmitglied: PBFA
EUR 9,56
Anzahl: 1 verfügbar
In den WarenkorbZustand: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Verlag: Performance Programme Dated Saturday 2nd March . 2002., 2002
Anbieter: Little Stour Books PBFA Member, Canterbury, Vereinigtes Königreich
Verbandsmitglied: PBFA
EUR 9,56
Anzahl: 1 verfügbar
In den WarenkorbZustand: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Verlag: Performance Programme Dated Saturday 12th March . 1994., 1994
Anbieter: Little Stour Books PBFA Member, Canterbury, Vereinigtes Königreich
Verbandsmitglied: PBFA
EUR 9,56
Anzahl: 1 verfügbar
In den WarenkorbZustand: Fine. Original stapled illustrated souvenir programme. 8½'' x 5½''. Contains 20 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Verlag: Performance Programme Dated Saturday 2nd March . 2002., 2002
Anbieter: Little Stour Books PBFA Member, Canterbury, Vereinigtes Königreich
Verbandsmitglied: PBFA
EUR 9,56
Anzahl: 1 verfügbar
In den WarenkorbZustand: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Sprache: Englisch
Verlag: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 119,95
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Sprache: Englisch
Verlag: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 119,94
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Sprache: Englisch
Verlag: Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: Rarewaves USA, OSWEGO, IL, USA
Hardback. Zustand: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Sprache: Englisch
Verlag: Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
EUR 154,81
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Sprache: Englisch
Verlag: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 141,06
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Emerald Publishing Limited, 2008
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 131,51
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Like New. Like New. book.
Sprache: Englisch
Verlag: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: Rarewaves USA United, OSWEGO, IL, USA
EUR 155,27
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 210,47
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 250 pages. 9.25x6.25x1.25 inches. In Stock.
Sprache: Englisch
Verlag: Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: Rarewaves.com UK, London, Vereinigtes Königreich
EUR 146,02
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Sprache: Englisch
Verlag: Emerald Group Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 124,44
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Sprache: Englisch
Verlag: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 143,49
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Anbieter: moluna, Greven, Deutschland
EUR 160,70
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. InhaltsverzeichnisContents: Introduction (I. Farquhar, K. Summers, A. Sorkin). INNOVATION IN REGULATORY AND OUTCOMES RESEARCH APPLICATIONS (1) After-Market Drug Regulation: Promoting Public Trust in Innovation (R. Field) (2) Transcendin.
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. Print on Demand pp. 250.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 236,90
Anzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand pp. 250.
Anbieter: preigu, Osnabrück, Deutschland
Buch. Zustand: Neu. Value of Innovation | Irina Farquhar (u. a.) | Buch | Gebunden | Englisch | 2008 | Jai Press Inc. | EAN 9780762313464 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND pp. 250.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs.